Rebalancing the Trisomic Genome: A Genetic Reset for Trisomy 21

By: Jewel Christi V. Umali | Chromoplexy

Trisomy 21, commonly known as Down Syndrome, is one of the most common genetic disorders causing intellectual disability (Antonarakis et al., 2020). Beyond cognitive impairment, people with Down syndrome often face serious medical conditions, such as congenital heart problems, leukemia, and early-onset Alzheimer's disease. These conditions result from a gene dosage imbalance, in which a third copy of chromosome 21 (HSA21) produces "genetic noise" by overproducing proteins.

Trisomy 21 – Brighton Center. (2025). Brightonsa.org. https://brightonsa.org/2023/03/14/trisomy-21/ 

A study conducted by Hashizume and colleagues in 2025, designed a method to "rescue" cells by surgically removing the excess chromosome while preserving the healthy ones. This methodology began with allele-specific fingerprinting and whole-genome sequencing to isolate the maternal M2 allele for elimination while preserving genetic diversity. The researchers then used multi-site CRISPR-Cas9 cleavage to cause simultaneous breaks across the targeted chromosome, utilizing 13 specialized guide RNAs (gRNAs). To complete the operation, the researchers used DNA repair inhibition to sabotage the cell's internal repair mechanism. By temporarily stopping these natural pathways, the researchers prevented the chromosome from reconstituting itself, forcing the cell to discard the fragmented genetic material during cell division.

The study observed that "Trisomic rescue" efficiently restores cellular defects by removing the extra chromosome and reversing the harmful effects of gene-dosage imbalance. This was confirmed via transcriptome analysis which showed that gene expression has been restored to normal levels and that the "genetic noise" that usually impairs cellular function has been silenced. Furthermore, the recovered cells demonstrated normalized proliferation, with growth rates and cell cycles comparable to healthy control cells, rather than entering premature senescence. Beyond growth, the researchers discovered a significant reduction in stress markers as well as better tissue-level activities like cell migration. Crucially, this functional reset was durable and efficient in both rapidly proliferating stem cells and non-dividing fibroblasts, resulting in a complete restoration of cellular health.

Irfan, U., Belluz, J., Plumer, B., & Barclay, E. (2018, December 27). A simple guide to CRISPR, one of the biggest science stories of the decade. Vox. https://www.vox.com/2018/7/23/17594864/crispr-cas9-gene-editing 

The study provides an important proof-of-concept for chromosomal treatment, effectively establishing a framework for restoring normal gene dosage by looking beyond symptom management to the genetic foundation of Down Syndrome. While clinical use is still in the works, this shredding technique allows for targeted therapies in specific organs such as neurons or bone marrow. Such improvements have the potential to reduce cognitive impairments and avert life-threatening consequences such as leukemia, paving the way for the theoretical reversal of cellular malfunction throughout entire organ systems.